Cantor Fitzgerald analyst Jennifer Kim reiterated an Overweight rating on Insmed (NASDAQ: INSM).The analyst commented, “Our chat with Gene leaves ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE